Official title: Phase I Clinical Trial of Cell Based Therapy for Duchenne Muscular Dystrophy Summary: This is a single-center, single-arm, interventional phase 1 trial to evaluate the safety and tolerability of local injection of induced pluripotent stem cell (iPSC)- derived CD54+ allogeneic muscle progenitor cells in individuals with Duchenne muscular dystrophy (DMD) Conditions: Duchenne Muscular Dystrophy Study type: INTERVENTIONAL Primary purpose: TREATMENT Phases: PHASE1 Enrollment: 8 (ESTIMATED) Status: RECRUITING Completion: 2027-03-03 (ESTIMATED)
ClinicalTrials.gov published a clinical update in Oncology on 04 Mar 2026.
The item focuses on Trial of Cell Based Therapy for DMD.
Review the original article for the full source wording and details.